Literature DB >> 7731720

B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.

C Papin1, A Eychène, A Brunet, G Pagès, J Pouysségur, G Calothy, J V Barnier.   

Abstract

The B-raf/c-Rmil proto-oncogene belongs to the raf/mil family of serine/threonine protein kinases. It encodes multiple protein isoforms resulting from alternative splicing of two exons located upstream of the kinase domain. Recent studies suggested that B-Raf could be the intermediate molecule between Ras and Mek-1 (MAP Kinase Kinase) in signalling pathways specific of neural cells. However, there has been no evidence for a direct interaction between B-Raf and Mek-1. We report here that different B-Raf isoforms can be co-immunoprecipitated with anti-Mek-1 antisera in COS-1 cells and that the kinase activity of B-Raf is not required for its interaction with Mek-1. We also show that all B-Raf isoforms tested phosphorylate Mek-1 in a time-dependent manner, whereas kinase defective mutants fail to do so. Finally, we demonstrate that the constitutively activated S218D, S222D and S218D/S222D mutants of Mek-1 interact similarly with B-Raf. However, only the S218D and S222D mutants, and not the S218D/S222D double mutant, can be phosphorylated by B-Raf isoforms. Therefore, serine residues 218 and 222, previously shown to regulate Mek-1 activity, appear to be the major phosphorylation sites by B-Raf in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731720

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway.

Authors:  Jens Rauch; Kim Moran-Jones; Valerie Albrecht; Thomas Schwarzl; Keith Hunter; Olivier Gires; Walter Kolch
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

Review 3.  Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.

Authors:  Daniel E Johnson
Journal:  Adv Enzyme Regul       Date:  2007-11-19

Review 4.  The molecular basis of ethylene signalling in Arabidopsis.

Authors:  K Woeste; J J Kieber
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-09-29       Impact factor: 6.237

Review 5.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

6.  The comparison between dual inhibition of mTOR with MAPK and PI3K signaling pathways in KRAS mutant NSCLC cell lines.

Authors:  Irem Dogan Turacli; Ayla Cihan Ozkan; Abdullah Ekmekci
Journal:  Tumour Biol       Date:  2015-06-25

7.  D53 is a novel endosomal SNARE-binding protein that enhances interaction of syntaxin 1 with the synaptobrevin 2 complex in vitro.

Authors:  Véronique Proux-Gillardeaux; Thierry Galli; Isabelle Callebaut; Anatoly Mikhailik; Georges Calothy; Maria Marx
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

Review 8.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

9.  Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.

Authors:  Jennifer D Cohen; Matthew Labenski; Nicholas J Mastrandrea; Ryan D Canatsey; Terrence J Monks; Serrine S Lau
Journal:  Mol Carcinog       Date:  2015-08-31       Impact factor: 4.784

10.  Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices.

Authors:  P Vanhoutte; J V Barnier; B Guibert; C Pagès; M J Besson; R A Hipskind; J Caboche
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.